Overview

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris

Status:
Completed

Trial end date:
2010-12-11

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the efficacy, safety, tolerability and the concentration/response relationship of E6201 in subjects with psoriasis vulgaris.

Phase:

Phase 2

Details

Lead Sponsor:

Eisai Limited

Treatments:

Calcipotriene